The WACC of GemVax & KAEL Co Ltd (082270.KQ) is 11.3%.
| Range | Selected | |
| Cost of equity | 9.50% - 13.80% | 11.65% |
| Tax rate | 22.10% - 22.30% | 22.20% |
| Cost of debt | 4.00% - 7.00% | 5.50% |
| WACC | 9.2% - 13.4% | 11.3% |
| Category | Low | High |
| Long-term bond rate | 3.1% | 3.6% |
| Equity market risk premium | 5.8% | 6.8% |
| Adjusted beta | 1.11 | 1.42 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 9.50% | 13.80% |
| Tax rate | 22.10% | 22.30% |
| Debt/Equity ratio | 0.05 | 0.05 |
| Cost of debt | 4.00% | 7.00% |
| After-tax WACC | 9.2% | 13.4% |
| Selected WACC | 11.3% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 082270.KQ:
cost_of_equity (11.65%) = risk_free_rate (3.35%) + equity_risk_premium (6.30%) * adjusted_beta (1.11) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.